|
000
| 00940nam##2200217za#4500 |
|---|
| 001 | 9.691033 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624232607 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2003||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aMR21-125/2003E-PDF |
|---|
| 110 | 2 |aCanadian Institutes of Health Research. |
|---|
| 245 | 10|aNational Placebo Initiative : |h[electronic resource]|bdraft report of the National Placebo Working Committee / |cSubmitted to Health Canada, Canadian Institutes of Health Research. |
|---|
| 260 | |aOttawa - Ontario : |bCanadian Institutes of Health Research |c2003. |
|---|
| 300 | |a97p.|breferences, tables |
|---|
| 590 | |a08-03-Supp|b2008-09-09 |
|---|
| 690 | 07|aPrescription drugs|2gcpds |
|---|
| 775 | 08|tInitiative nationale sur les placebos : |w(CaOODSP)9.635375 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s581 KB|uhttps://publications.gc.ca/collections/collection_2008/cihr-irsc/MR21-125-2003E.pdf |
|---|